Inogen, Inc. (INGN)
5.97
-0.01
(-0.17%)
USD |
NASDAQ |
Oct 02, 16:00
5.96
-0.01
(-0.17%)
After-Hours: 20:00
Inogen EPS Diluted (Quarterly) : -0.1424 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1424 |
| March 31, 2026 | -0.3047 |
| December 31, 2025 | -0.2622 |
| September 30, 2025 | -0.1955 |
| June 30, 2025 | -0.154 |
| March 31, 2025 | -0.2454 |
| December 31, 2024 | -0.4092 |
| September 30, 2024 | -0.2511 |
| June 30, 2024 | -0.2367 |
| March 31, 2024 | -0.623 |
| December 31, 2023 | -1.139 |
| September 30, 2023 | -1.968 |
| June 30, 2023 | -0.4245 |
| March 31, 2023 | -0.8844 |
| December 31, 2022 | -2.469 |
| September 30, 2022 | -0.4154 |
| June 30, 2022 | -0.1507 |
| March 31, 2022 | -0.6247 |
| December 31, 2021 | -1.007 |
| September 30, 2021 | 0.5327 |
| June 30, 2021 | 0.223 |
| March 31, 2021 | -0.033 |
| December 31, 2020 | -0.2323 |
| September 30, 2020 | -0.0772 |
| June 30, 2020 | 0.1161 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0725 |
| December 31, 2019 | -0.0628 |
| September 30, 2019 | 0.3093 |
| June 30, 2019 | 0.4544 |
| March 31, 2019 | 0.2353 |
| December 31, 2018 | 0.4445 |
| September 30, 2018 | 0.7252 |
| June 30, 2018 | 0.65 |
| March 31, 2018 | 0.4825 |
| December 31, 2017 | -0.03 |
| September 30, 2017 | 0.33 |
| June 30, 2017 | 0.38 |
| March 31, 2017 | 0.27 |
| December 31, 2016 | 0.25 |
| September 30, 2016 | 0.25 |
| June 30, 2016 | 0.36 |
| March 31, 2016 | 0.12 |
| December 31, 2015 | 0.19 |
| September 30, 2015 | 0.13 |
| June 30, 2015 | 0.17 |
| March 31, 2015 | 0.08 |
| December 31, 2014 | 0.07 |
| September 30, 2014 | 0.11 |
| June 30, 2014 | 0.11 |
| March 31, 2014 | -0.0054 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Inspire Medical Systems, Inc. | 0.0108 |
| IDEXX Laboratories, Inc. | 4.267 |
| Stryker Corp. | 3.306 |
| Zimmer Biomet Holdings, Inc. | 1.028 |
| Enovis Corp. | -0.0207 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.85M |
| Revenue (Quarterly) | 95.08M |
| Total Expenses (Quarterly) | 98.93M |
| Enterprise Value | 68.53M |
| Gross Profit Margin (Quarterly) | 53.39% |
| Profit Margin (Quarterly) | -4.05% |
| Earnings Yield | -15.16% |
| Normalized Earnings Yield | -14.67 |